{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:50:13Z","timestamp":1781106613158,"version":"3.54.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.neulet.2023.137561","type":"journal-article","created":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T22:23:18Z","timestamp":1700432598000},"page":"137561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Promising efficacy of Low-Dose rituximab in Muscle specific kinase antibody positive Myasthenia Gravis"],"prefix":"10.1016","volume":"818","author":[{"given":"Xishuai","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuopeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runquan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3492-7384","authenticated-orcid":false,"given":"Junhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2023.137561_b0005","doi-asserted-by":"crossref","unstructured":"Jeffrey T. Guptill, John S. Yi, et al,Characterization of B cells in muscle-specific kinase antibody myasthenia gravis, J. Neurology: Neuroimmunol Neuroinflamm. 2 (2015) e77. https:\/\/doi.org\/10.1212\/NXI.0000000000000077.","DOI":"10.1212\/NXI.0000000000000077"},{"issue":"4","key":"10.1016\/j.neulet.2023.137561_b0010","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/annonc\/mdg175","article-title":"An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab","volume":"14","author":"Boye","year":"2003","journal-title":"J Ann Oncol."},{"key":"10.1016\/j.neulet.2023.137561_b0015","doi-asserted-by":"crossref","unstructured":"Raffaele Iorio , Valentina Damato, et al., Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis, J.J Neurol.2014.262.(5).\uff081115-9\uff09\uff1bhttps:\/\/doi.org\/10.1007\/s00415-014-7532-3.","DOI":"10.1007\/s00415-014-7532-3"},{"issue":"6","key":"10.1016\/j.neulet.2023.137561_b0020","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/mus.27233","article-title":"Short-term effect of low-dose rituximab on myasthenia gravis with muscle-specific tyrosine kinase antibody","volume":"63","author":"Zhou","year":"2021","journal-title":"J Muscle Nerve."},{"issue":"3","key":"10.1016\/j.neulet.2023.137561_b0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia","volume":"78","author":"Diaz-Manera","year":"2012","journal-title":"J Neurology."},{"key":"10.1016\/j.neulet.2023.137561_b0030","doi-asserted-by":"crossref","unstructured":"Michael K. Hehir, Lisa D. Hobson-Webb, Michael Benatar et al., Rituximab as treatment for anti-MuSK myasthenia gravis, J.American Academy of Neurology.2017.89(1-9)\uff1bhttps:\/\/doi.org\/10.1212\/WNL.0000000000004341.","DOI":"10.1212\/WNL.0000000000004341"},{"key":"10.1016\/j.neulet.2023.137561_b0035","article-title":"Differential response to rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study","volume":"411","author":"Litchman","year":"2020","journal-title":"J. J Neurol Sci."},{"key":"10.1016\/j.neulet.2023.137561_b0040","doi-asserted-by":"crossref","unstructured":"Nishita Singh, Vinay Goyal, Rituximab as induction therapy in refractory myasthenia gravis: 18 month follow-up study, J.J Neurol.2019.266.(7).\uff081596-1600\uff09\uff1bhttps:\/\/doi.org\/10.1007\/s00415-019-09296-y.","DOI":"10.1007\/s00415-019-09296-y"},{"issue":"7","key":"10.1016\/j.neulet.2023.137561_b0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.nmd.2019.06.002","article-title":"Stopping oral steroid-sparing agents at initiation of rituximab in myasthenia gravis","volume":"29","author":"Roda","year":"2019","journal-title":"J Neuromuscul Disord."},{"issue":"2","key":"10.1016\/j.neulet.2023.137561_b0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/JND-180300","article-title":"Efficacy of rituximab in refractory generalized anti-achr myasthenia gravis","volume":"5","author":"Landon-Cardinal","year":"2018","journal-title":"J.J Neuromuscul Dis."},{"key":"10.1016\/j.neulet.2023.137561_b0055","doi-asserted-by":"crossref","unstructured":"KM Kanth, GE Solorzano, et al., PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents, J.Neurol Clin Pract.2016.6.(e17-9).https:\/\/doi.org\/10.1212\/CPJ.0000000000000202.","DOI":"10.1212\/CPJ.0000000000000202"},{"key":"10.1016\/j.neulet.2023.137561_b0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.nmd.2016.12.004","article-title":"Resistant myasthenia gravis and rituximab: a monocentric retrospective study of 28 patients","volume":"27","author":"Afanasiev","year":"2017","journal-title":"J. Neuromuscul Disord."},{"issue":"2","key":"10.1016\/j.neulet.2023.137561_b0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.25597","article-title":"et al., Rituximab treatment of myasthenia gravis: a systematic review","volume":"56","author":"Tandan","year":"2017","journal-title":"J Muscle Nerve."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023005207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023005207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T09:57:07Z","timestamp":1736330227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394023005207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":13,"alternative-id":["S0304394023005207"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137561","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising efficacy of Low-Dose rituximab in Muscle specific kinase antibody positive Myasthenia Gravis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"137561"}}